Literature DB >> 22249333

Metabolic decompensation in methylmalonic aciduria: which biochemical parameters are discriminative?

Tamaris Zwickler1, Gisela Haege, Alina Riderer, Friederike Hörster, Georg F Hoffmann, Peter Burgard, Stefan Kölker.   

Abstract

Recurrent, life-threatening metabolic decompensations often occur in patients with methylmalonic aciduria (MMAuria). Our study evaluated (impending) metabolic decompensations in these patients aiming to identify the most frequent and reliable clinical and biochemical abnormalities that could be helpful for decision-making on when to start an emergency treatment. Seventy-six unscheduled and 179 regular visits of 10 patients with confirmed MMAuria continuously followed by our metabolic centre between 1975 and 2009 were analysed. The most frequent symptom of an impending acute metabolic decompensation was vomiting (90% of episodes), whereas symptoms of intercurrent infectious disease (29%) or other symptoms (such as food refusal and impaired consciousness) were found less often. Thirty-five biochemical parameters were included in the analysis. Among them, pathological changes of acid-base balance reflecting metabolic acidosis with partial respiratory compensation (decreased pH, pCO(2), standard bicarbonate, and base excess) and elevated ammonia were the most reliable biochemical parameters for the identification of a metabolic decompensation and the estimation of its severity. In contrast, analyses of organic acids, acylcarnitines and carnitine status were less discriminative. In conclusion, careful history taking and identification of suspicious symptoms in combination with a small number of rapidly available biochemical parameters are helpful to differentiate compensated metabolic condition and (impending) metabolic crisis and to decide when to start an emergency treatment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22249333     DOI: 10.1007/s10545-011-9426-1

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  19 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  Secondary mitochondrial dysfunction in propionic aciduria: a pathogenic role for endogenous mitochondrial toxins.

Authors:  Marina A Schwab; Sven W Sauer; Jürgen G Okun; Leo G J Nijtmans; Richard J T Rodenburg; Lambert P van den Heuvel; Stefan Dröse; Ulrich Brandt; Georg F Hoffmann; Henk Ter Laak; Stefan Kölker; Jan A M Smeitink
Journal:  Biochem J       Date:  2006-08-15       Impact factor: 3.857

3.  Neurodegeneration in methylmalonic aciduria involves inhibition of complex II and the tricarboxylic acid cycle, and synergistically acting excitotoxicity.

Authors:  Jürgen G Okun; Friederike Hörster; Lilla M Farkas; Patrik Feyh; Angela Hinz; Sven Sauer; Georg F Hoffmann; Klaus Unsicker; Ertan Mayatepek; Stefan Kölker
Journal:  J Biol Chem       Date:  2002-02-14       Impact factor: 5.157

4.  Long-term follow-up of 77 patients with isolated methylmalonic acidaemia.

Authors:  E R Baumgarter; C Viardot
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

5.  The use of amino acid supplements in inherited metabolic disease.

Authors:  John H Walter; Anita MacDonald
Journal:  J Inherit Metab Dis       Date:  2006 Apr-Jun       Impact factor: 4.982

Review 6.  Methylmalonic and propionic aciduria.

Authors:  Federica Deodato; Sara Boenzi; Filippo M Santorelli; Carlo Dionisi-Vici
Journal:  Am J Med Genet C Semin Med Genet       Date:  2006-05-15       Impact factor: 3.908

7.  Molecular identification of a renal urate anion exchanger that regulates blood urate levels.

Authors:  Atsushi Enomoto; Hiroaki Kimura; Arthit Chairoungdua; Yasuhiro Shigeta; Promsuk Jutabha; Seok Ho Cha; Makoto Hosoyamada; Michio Takeda; Takashi Sekine; Takashi Igarashi; Hirotaka Matsuo; Yuichi Kikuchi; Takashi Oda; Kimiyoshi Ichida; Tatsuo Hosoya; Kaoru Shimokata; Toshimitsu Niwa; Yoshikatsu Kanai; Hitoshi Endou
Journal:  Nature       Date:  2002-04-14       Impact factor: 49.962

8.  Prediction of outcome in isolated methylmalonic acidurias: combined use of clinical and biochemical parameters.

Authors:  F Hörster; S F Garbade; T Zwickler; H I Aydin; O A Bodamer; A B Burlina; A M Das; J B C De Klerk; C Dionisi-Vici; S Geb; G Gökcay; N Guffon; E M Maier; E Morava; J H Walter; B Schwahn; F A Wijburg; M Lindner; S Grünewald; M R Baumgartner; S Kölker
Journal:  J Inherit Metab Dis       Date:  2009-07-31       Impact factor: 4.982

9.  Inherited methylmalonyl CoA mutase apoenzyme deficiency in human fibroblasts: evidence for allelic heterogeneity, genetic compounds, and codominant expression.

Authors:  H F Willard; L E Rosenberg
Journal:  J Clin Invest       Date:  1980-03       Impact factor: 14.808

10.  The impact of screening for propionic and methylmalonic acidaemia.

Authors:  James V Leonard; Suresh Vijayaraghavan; John H Walter
Journal:  Eur J Pediatr       Date:  2003-10-30       Impact factor: 3.183

View more
  17 in total

1.  The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: the initial presentation.

Authors:  Stefan Kölker; Angeles Garcia-Cazorla; Angeles Garcia Cazorla; Vassili Valayannopoulos; Allan M Lund; Alberto B Burlina; Jolanta Sykut-Cegielska; Frits A Wijburg; Elisa Leão Teles; Jiri Zeman; Carlo Dionisi-Vici; Ivo Barić; Daniela Karall; Persephone Augoustides-Savvopoulou; Lise Aksglaede; Jean-Baptiste Arnoux; Paula Avram; Matthias R Baumgartner; Javier Blasco-Alonso; Brigitte Chabrol; Anupam Chakrapani; Kimberly Chapman; Elisenda Cortès I Saladelafont; Maria L Couce; Linda de Meirleir; Dries Dobbelaere; Veronika Dvorakova; Francesca Furlan; Florian Gleich; Wanda Gradowska; Stephanie Grünewald; Anil Jalan; Johannes Häberle; Gisela Haege; Robin Lachmann; Alexander Laemmle; Eveline Langereis; Pascale de Lonlay; Diego Martinelli; Shirou Matsumoto; Chris Mühlhausen; Hélène Ogier de Baulny; Carlos Ortez; Luis Peña-Quintana; Danijela Petković Ramadža; Esmeralda Rodrigues; Sabine Scholl-Bürgi; Etienne Sokal; Christian Staufner; Marshall L Summar; Nicholas Thompson; Roshni Vara; Inmaculada Vives Pinera; John H Walter; Monique Williams; Peter Burgard
Journal:  J Inherit Metab Dis       Date:  2015-04-15       Impact factor: 4.982

Review 2.  The liver is a metabolic and immunologic organ: A reconsideration of metabolic decompensation due to infection in inborn errors of metabolism (IEM).

Authors:  Tatyana N Tarasenko; Peter J McGuire
Journal:  Mol Genet Metab       Date:  2017-06-24       Impact factor: 4.797

Review 3.  Renal dysfunction in methylmalonic acidurias: review for the pediatric nephrologist.

Authors:  Marina A Morath; Friederike Hörster; Sven W Sauer
Journal:  Pediatr Nephrol       Date:  2012-07-20       Impact factor: 3.714

4.  Biochemical and anaplerotic applications of in vitro models of propionic acidemia and methylmalonic acidemia using patient-derived primary hepatocytes.

Authors:  M Sol Collado; Allison J Armstrong; Matthew Olson; Stephen A Hoang; Nathan Day; Marshall Summar; Kimberly A Chapman; John Reardon; Robert A Figler; Brian R Wamhoff
Journal:  Mol Genet Metab       Date:  2020-05-11       Impact factor: 4.797

5.  Usefulness of biochemical parameters in decision-making on the start of emergency treatment in patients with propionic acidemia.

Authors:  Tamaris Zwickler; Alina Riderer; Gisela Haege; Georg F Hoffmann; Stefan Kölker; Peter Burgard
Journal:  J Inherit Metab Dis       Date:  2013-06-25       Impact factor: 4.982

6.  Methylmalonic Acid Impairs Cell Respiration and Glutamate Uptake in C6 Rat Glioma Cells: Implications for Methylmalonic Acidemia.

Authors:  Renata T Costa; Marcella B Santos; Carlos Alberto-Silva; Daniel C Carrettiero; César A J Ribeiro
Journal:  Cell Mol Neurobiol       Date:  2022-06-08       Impact factor: 5.046

7.  Clinical characteristics of hemolytic uremic syndrome secondary to cobalamin C disorder in Chinese children.

Authors:  Qi-Liang Li; Wen-Qi Song; Xiao-Xia Peng; Xiao-Rong Liu; Le-Jian He; Li-Bing Fu
Journal:  World J Pediatr       Date:  2015-08-08       Impact factor: 2.764

Review 8.  Methylmalonic and propionic acidemias: clinical management update.

Authors:  Jamie L Fraser; Charles P Venditti
Journal:  Curr Opin Pediatr       Date:  2016-12       Impact factor: 2.856

9.  Guidelines for the diagnosis and management of methylmalonic acidaemia and propionic acidaemia: First revision.

Authors:  Patrick Forny; Friederike Hörster; Diana Ballhausen; Anupam Chakrapani; Kimberly A Chapman; Carlo Dionisi-Vici; Marjorie Dixon; Sarah C Grünert; Stephanie Grunewald; Goknur Haliloglu; Michel Hochuli; Tomas Honzik; Daniela Karall; Diego Martinelli; Femke Molema; Jörn Oliver Sass; Sabine Scholl-Bürgi; Galit Tal; Monique Williams; Martina Huemer; Matthias R Baumgartner
Journal:  J Inherit Metab Dis       Date:  2021-03-09       Impact factor: 4.750

10.  Brain damage in methylmalonic aciduria: 2-methylcitrate induces cerebral ammonium accumulation and apoptosis in 3D organotypic brain cell cultures.

Authors:  Paris Jafari; Olivier Braissant; Petra Zavadakova; Hugues Henry; Luisa Bonafé; Diana Ballhausen
Journal:  Orphanet J Rare Dis       Date:  2013-01-08       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.